SMU Cox School of Business: The Business of Business School
Matthew Myers has been the Dean of the Cox School of Business at Southern Methodist University since August 2017. Myers has been working with the leadership team at SMU to continue attracting students to SMU and building out their STEM program collaborations.
While Business school enrollment is down overall, SMU is doing their part to attract talent and interest. Myers explains that enrollment is down for a number of reasons. MBA degrees are more expensive than undergraduate degrees, and as undergrad programs continue to improve in the field of business, the education gap between the two programs is decreasing.
Myers also explains that SMU keeps an eye on NAFTA. Myers says that Mexico is a huge partner of Texas and SMU. He also notes that the general rhetoric out of Washington about immigration impacts what the strongest students in Latin America think about pursuing an education in the U.S.
For the Cox School of Business, tech is a huge focus. The
Cox Business School works closely with the engineering school in order to integrate classes and enable students to have a multi-faceted education and career. The Master of Science in Finance degree offered at the business school will be STEM designated next in Fall 2018.
Jay Hatfield, chief investment officer for ICAP, joined Cheddar News to discuss how markets are reacting to labor market news and what the Federal Reserve will do next in terms of interest rates.
Kristin Cavallari, who first gained fame as a cast member of the MTV reality show Laguna Beach, is now the founder of a beauty company called Uncommon James. Cheddar News anchor Hena Doba took a walk with Cavallari to discuss her many business ventures.
Heardle, the name-that-tune game inspired by the Wordle craze, is being dropped by Spotify less than a year after the music-streaming giant acquired it.
Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Keytruda on its own, according to researchers.
